These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18288754)

  • 21. SEDUCEd by optical coherence tomography in drug-eluting balloon assessment.
    Chan YH; Agostoni P
    EuroIntervention; 2014 Aug; 10(4):415-7. PubMed ID: 25138178
    [No Abstract]   [Full Text] [Related]  

  • 22. Oxidative stress and pathological changes after coronary artery interventions.
    Juni RP; Duckers HJ; Vanhoutte PM; Virmani R; Moens AL
    J Am Coll Cardiol; 2013 Apr; 61(14):1471-81. PubMed ID: 23500310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
    Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
    Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. If I've heard it once, I've heard it (not yet) a hundred times.
    Butman SM
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):502. PubMed ID: 21351224
    [No Abstract]   [Full Text] [Related]  

  • 25. Fractional flow reserve-guided stent therapy for multivessel disease: taking a closer look.
    Applegate RJ
    J Am Coll Cardiol; 2010 Jun; 55(25):2822-4. PubMed ID: 20579538
    [No Abstract]   [Full Text] [Related]  

  • 26. Coronary stents reduce restenosis and repeat revascularizations and may also improve survival.
    Vik-Mo H; Bønaa KH
    Scand Cardiovasc J; 2004 Aug; 38(4):195-6. PubMed ID: 15553928
    [No Abstract]   [Full Text] [Related]  

  • 27. Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry.
    Park KW; Kang SH; Park KH; Choi DH; Lee HY; Kang HJ; Cho YS; Yeon TJ; Chung WY; Koo BK; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS
    Int J Cardiol; 2011 Aug; 151(1):89-95. PubMed ID: 20605240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
    Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
    Adriaenssens T; Dens J; Ughi G; Bennett J; Dubois C; Sinnaeve P; Wiyono S; Coosemans M; Belmans A; D'hooge J; Vrolix M; Desmet W
    EuroIntervention; 2014 Aug; 10(4):439-48. PubMed ID: 25138182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results.
    López Mínguez JR; Nogales Asensio JM; Doncel Vecino LJ; Sandoval J; Romany S; Martínez Romero P; Fernández Díaz JA; Fernández Portales J; González Fernández R; Martínez Cáceres G; Merchán Herrera A; Alfonso Manterola F;
    EuroIntervention; 2014 May; 10(1):50-7. PubMed ID: 24832638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-eluting stents. The third revolution in percutaneous coronary intervention.
    Saia F; Marzocchi A; Serruys PW
    Ital Heart J; 2005 Apr; 6(4):289-303. PubMed ID: 15902927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brachytherapy and drug-eluting stents.
    Moses JW
    J Invasive Cardiol; 2003 Mar; 15 Suppl B():30B-32B; discussion 32B-33B. PubMed ID: 12724584
    [No Abstract]   [Full Text] [Related]  

  • 33. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial.
    Räber L; Wohlwend L; Wigger M; Togni M; Wandel S; Wenaweser P; Cook S; Moschovitis A; Vogel R; Kalesan B; Seiler C; Eberli F; Lüscher TF; Meier B; Jüni P; Windecker S
    Circulation; 2011 Jun; 123(24):2819-28, 6 p following 2828. PubMed ID: 21646500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents.
    Mishkel GJ; Moore AL; Markwell S; Shelton MC; Shelton ME
    J Am Coll Cardiol; 2007 Jan; 49(2):181-4. PubMed ID: 17222728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting stents and rotational atherectomy--"no 'roto' regret".
    Vidovich MI
    J Invasive Cardiol; 2011 Apr; 23(4):140. PubMed ID: 21474845
    [No Abstract]   [Full Text] [Related]  

  • 36. Restenosis following thin-strut bare-metal stents versus thick-strut drug-eluting stents.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):799-800. PubMed ID: 17377984
    [No Abstract]   [Full Text] [Related]  

  • 37. QT interval dispersion as a new marker of restenosis after percutaneous transluminal coronary angioplasty.
    Krishnamoorthy KM; Dash PK
    Cardiology; 2007; 108(1):71-2. PubMed ID: 17003544
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.
    Chevalier B; Di Mario C; Neumann FJ; Ribichini F; Urban P; Popma JJ; Fitzgerald PJ; Cutlip DE; Williams DO; Ormiston J; Grube E; Whitbourn R; Schwartz LB;
    JACC Cardiovasc Interv; 2008 Oct; 1(5):524-32. PubMed ID: 19463354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-month angiographic and one-year clinical outcomes of polymer free paclitaxel-eluting stent in patients with ST-segment elevation myocardial infarction: a comparison with permanent polymer sirolimus-eluting stent.
    Dang Q; Li YJ; Gao L; Jin Z; Gou LX
    Chin Med J (Engl); 2012 Oct; 125(19):3393-7. PubMed ID: 23044294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of sirolimus- and paclitaxel-eluting stents in patients with moderate renal insufficiency: results from the J-DESsERT trial.
    Otsuka M; Yokoi H; Matsuyama Y; Hayashi Y; Shiode N; Masaoka Y; Okimoto T; Tamekiyo H; Kawase T; Yamane K; Kagawa Y; Nakamura M; Muramatsu T; Nanto S;
    Cardiovasc Revasc Med; 2014; 15(6-7):323-8. PubMed ID: 25284808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.